This topic contains a solution. Click here to go to the answer

Author Question: An individual's belief about having the capacity to perform a task is called: A) goal commitment. ... (Read 112 times)

rl

  • Hero Member
  • *****
  • Posts: 579
An individual's belief about having the capacity to perform a task is called:
 
  A) goal commitment.
  B) goal setting.
  C) self-actualization.
  D) self-efficacy.

Question 2

What is the final link in the communication process?
 
  A) Decode. B) Encode. C) Channel. D) Feedback.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

livaneabi

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

D

Answer to Question 2

D




rl

  • Member
  • Posts: 579
Reply 2 on: Jul 7, 2018
Great answer, keep it coming :)


sarah_brady415

  • Member
  • Posts: 328
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Once thought to have neurofibromatosis, Joseph Merrick (also known as "the elephant man") is now, in retrospect, thought by clinical experts to have had Proteus syndrome. This endocrine disease causes continued and abnormal growth of the bones, muscles, skin, and so on and can become completely debilitating with severe deformities occurring anywhere on the body.

Did you know?

In 2006, a generic antinausea drug named ondansetron was approved. It is used to stop nausea and vomiting associated with surgery, chemotherapy, and radiation therapy.

Did you know?

When intravenous medications are involved in adverse drug events, their harmful effects may occur more rapidly, and be more severe than errors with oral medications. This is due to the direct administration into the bloodstream.

Did you know?

Medications that are definitely not safe to take when breastfeeding include radioactive drugs, antimetabolites, some cancer (chemotherapy) agents, bromocriptine, ergotamine, methotrexate, and cyclosporine.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library